ABOUT
R&D PHARMA
Scientific Leadership
Scientific expertise supporting innovation
At R&D Pharma, scientific expertise and rigorous research are essential to advancing innovation in dermatology. Our scientific perspective benefits from the guidance of internationally recognized specialists with strong experience in Clinical research, Regulatory affairs, Quality management, Pharmaceutical affairs and Medical device development.
Professor Thierry Passeron, MD, PhD
Scientific Advisor
Professor Thierry Passeron is an internationally recognized dermatologist and researcher. He is Professor and Head of the Department of Dermatology at Nice University Hospital, France, and leads a research team at INSERM U1065 (C3M) investigating molecular mechanisms involved in pigmentation and melanoma.
His scientific career includes more than 410 publications and 16 international patents. His honors include the Galien Prize, the Grand Prize Robert Debré for Medical Research, and appointment as Chevalier of the French National Order of Merit.
As Scientific Advisor to R&D Pharma, Professor Passeron brings his distinguished scientific expertise and extensive research experience to support the company’s scientific vision and long-term commitment to innovation in dermatology.
Founded in 2001 and headquartered in the Principality of Monaco, R&D Pharma is an independent, mid-sized pharmaceutical laboratory dedicated to the responsible development and commercialization of therapeutic solutions.
ORGANIZATION
As a focused and agile organization, R&D Pharma combines regulatory expertise with close operational oversight, allowing for efficient decision-making and strong scientific engagement.
REGULATORY FRAMEWORK
Operating as a Marketing Authorization Holder (MAH) and holding exploitant status under French regulatory law, a framework that combines wholesale distribution with specific post-marketing obligations, the company oversees regulatory strategy, pharmacovigilance, product lifecycle management, and batch release activities for its authorized medicinal products.
MANUFACTURING & QUALITY
R&D Pharma holds the appropriate GMP authorization related to batch certification and release, enabling strengthened quality control and close collaboration with qualified GMP-compliant CDMO partners responsible for manufacturing.
Over time, the company has expanded into dermatology and technology-driven therapeutic approaches. Today, R&D Pharma develops and manufactures dermatological medical devices and advances investigational technologies through structured clinical evaluation programs.
Join our
Team:
If you are interested by joining our agile and expert team, please contact us.